Healthcare
The specialized division of QC Growth, pairing a proven go-to-market sales model with deep healthcare and software business expertise, purpose-built for Seed-to-Series A founders ready to accelerate commercialization.

Who is this for
We specialize in go-to-market support for tech-enabled healthcare services looking to reach that next stage of growth. Whether you are selling to Providers, Payers, Pharma, or still determining your core ICP, we accelerate your market signal while scaling pipeline.
Companies prioritizing regulatory approval before being commercial-ready.

Too early for a full engagement? Start with The GTM Co-Founder, our free, open-source GTM skills for founders doing it alone.
The problem
Healthcare commercialization is not like any other market. Long sales cycles, complex stakeholder maps, reimbursement hurdles, and compliance guardrails require deep domain expertise, not a generalist agency.

First way it goes wrong
In a market this crowded, the team that gets in the room first sets the requirements everyone else has to match. Waiting for a polished product means pitching into a decision that’s already been made.
Second way it goes wrong
Buyers commit early and rarely revisit. Once they’ve chosen who they trust to solve this problem, reopening that conversation gets harder every month you wait.
Third way it goes wrong
Founders hold off on commercial motion until the product feels finished. By then the buying committee has already chosen who they trust.
Strategy
Positioning, ICP, and the story that lands with each unique decision maker and champion within the buying committee.
Execution
Highly targeted, multi-channel campaign execution, reaching decision makers and champions at scale. Automating personalized sequences and SDR-level management to generate qualified meetings with core ICP.
GTM engineering
The stack that turns product usage into pipeline: intent signals, attribution, CRM, and automation wired to your own data.
Operations
The RevOps and process that make it repeatable: forecasting your board can trust, CRM data that holds up to scrutiny, and playbooks a new rep can run on day one
Solution
An embedded team of seasoned healthcare operators and GTM experts
01
02
03
The team
%2520(1)_converted.avif)
A healthcare GTM leader, bringing over a decade of experience driving growth for digital health companies. Kori spent the past 10+ years at Red Ventures and RVO Health, where her journey in health began after the company acquired Healthline.com, one of the leading consumer health media properties in the country.

Secured 15 buyer-level meetings in 90 days for Bluevia Health, without an existing hospital network to draw on.
Built a pre-seed advisory council of C-suite hospital executives from a standing start for Steadywell.
Unlocked outbound pipeline for Hemaptics through internal doctors’ networks and clinical credibility, not cold outreach.
We rebuild your CRM’s object model, pipeline stages, and lead routing so every rep works from the same source of truth.
Intent and technographic tracking built in Clay, AI Ark, or your existing stack, tuned to your buyer’s real behavior.

Live dashboards that turn activity data into pipeline visibility for you and your investors, not just your reps.
Scoring models and routing rules that get the right lead to the right rep before it goes cold.
We choose and configure the CRM, enrichment, and outbound tools that fit your stage, not the ones that fit an agency’s retainer.
Playbooks and recorded training so your team owns the system the day we hand it back.
Advisory councils, clinician networks and conference-driven signal intelligence, so you reach provider, payer and pharma buyers through credibility rather than volume.
Nine to eighteen months is normal for provider and payer deals. The lever is not speed of outreach, it is getting into the room before the requirements are written, because buyers commit early and rarely revisit.
The division is led by Kori Bivens, a former VP at RVO Health with over ten years in healthcare. Vertical fluency is the product, not a positioning line.
All three, and we help you work out which is actually your core ICP if that is still open. Healthcare is not one market and the segment economics differ.
Generally no. If regulatory approval has to land before you can be commercial, we are early. The fit is founders ready to accelerate commercialization now.
Through networks and credibility rather than volume: advisory councils, clinician networks, and conference-driven signal intelligence with a follow-through system behind it.
The fastest way to see how we think is a growth audit of your current GTM, no pitch, just where the leverage is.
Book Time